» Articles » PMID: 19863227

Dose Prescription and Optimisation Based on Tumour Hypoxia

Overview
Journal Acta Oncol
Specialty Oncology
Date 2009 Oct 30
PMID 19863227
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

INTRODUCTION. Tumour hypoxia is an important factor that confers radioresistance to the affected cells and could thus decrease the tumour response to radiotherapy. The development of advanced imaging methods that quantify both the extent and the spatial distribution of the hypoxic regions has created the premises to devise therapies that target the hypoxic regions in the tumour. MATERIALS AND METHODS. The present study proposes an original method to prescribe objectively dose distributions that focus the radiation dose to the radioresistant tumour regions and could therefore spare adjacent normal tissues. The effectiveness of the method was tested for clinically relevant simulations of tumour hypoxia that take into consideration dynamics and heterogeneity of oxygenation. RESULTS AND DISCUSSION. The results have shown that highly heterogeneous dose distributions may lead to significant improvements of the outcome only for static oxygenations. In contrast, the proposed method that involves the segmentation of the dose distributions and the optimisation of the dose prescribed to each segment to account for local heterogeneity may lead to significantly improved local control for clinically-relevant patterns of oxygenation. The clinical applicability of the method is warranted by its relatively easy adaptation to functional imaging of tumour hypoxia obtained with markers with known uptake properties.

Citing Articles

Photon and Proton Dose Painting Based on Oxygen Distribution - Feasibility Study and Tumour Control Probability Assessment.

Ureba A, Oden J, Toma-Dasu I, Lazzeroni M Adv Exp Med Biol. 2022; 1395:223-228.

PMID: 36527641 DOI: 10.1007/978-3-031-14190-4_37.


Evaluation of the Response of HNSCC Cell Lines to γ-Rays and C Ions: Can Radioresistant Tumors Be Identified and Selected for C Ion Radiotherapy?.

Ding L, Sishc B, Polsdofer E, Yordy J, Facoetti A, Ciocca M Front Oncol. 2022; 12:812961.

PMID: 35280731 PMC: 8914432. DOI: 10.3389/fonc.2022.812961.


Biologically Targeted Radiation Therapy: Incorporating Patient-Specific Hypoxia Data Derived from Quantitative Magnetic Resonance Imaging.

Her E, Haworth A, Sun Y, Williams S, Reynolds H, Kennedy A Cancers (Basel). 2021; 13(19).

PMID: 34638382 PMC: 8507789. DOI: 10.3390/cancers13194897.


Assessment of the Probability of Tumour Control for Prescribed Doses Based on Imaging of Oxygen Partial Pressure.

Ureba A, Kjellsson Lindblom E, Toma-Dasu I, Dasu A, Lazzeroni M Adv Exp Med Biol. 2021; 1269:185-190.

PMID: 33966215 DOI: 10.1007/978-3-030-48238-1_29.


Optimization of treatment planning for hypoxic tumours and re-modulation of radiation intensity in heavy-ion radiotherapy.

Rezaee L Rep Pract Oncol Radiother. 2020; 25(1):68-78.

PMID: 31889925 PMC: 6933175. DOI: 10.1016/j.rpor.2019.12.014.